Trevi Therapeutics, Inc. TRVI Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -33.6%-3.4pp | -30.2%+6.6pp | -36.9%-1.1pp | -35.7%+19.4pp | -55.1%-2.5pp | |
| Return on invested capital | -45%-2.4pp | -42.6%+15.2pp | -57.8%+17.6pp | -75.3%-2.8pp | -72.5%+14.7pp | |
| Liquidity | ||||||
| Current ratio | 24.8×+5.1× | 19.7×-2.3× | 21.9×-0.5× | 22.4×+7.0× | 15.4×+5.0× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $1.18-13.1% | $1.36+4.0% | $1.31-14.1% | $1.52+80.1% | $0.85-13.5% | |
| Valuation | ||||||
| Market capitalization | $1.53B-4.6% | $1.61B+44.1% | $1.11B+58.6% | $702.53M+15.5% | $608.13M+65.2% | |
| Price / book | 8.9×+0.1× | 8.8×+2.9× | 5.9×+2.3× | 3.5×-2.6× | 6.1×+2.4× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Trevi Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from Trevi Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.